REQUEST A DEMO
Total
USD $0.00
Search more companies

Domal Pharma S A S (Colombia)

Main Activities: All Other Miscellaneous Fabricated Metal Product Manufacturing
Full name: Domal Pharma S A S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Domal Pharma S A S is an enterprise in Colombia, with the main office in Bogota D.C.. The enterprise currently operates in the All Other Miscellaneous Fabricated Metal Product Manufacturing sector. It was established on November 05, 2014. It currently has a total number of 10 (2025) employees. The latest financial highlights indicate a net sales revenue drop of 33.34% in 2024. Its total assets grew by 51.44% over the same period. In 2024, Domal Pharma S A S’s net profit margin increased by 6.22%.

Headquarters
Cl 25 D # 85 C 62
Bogota D.C.; Bogota D.C; Postal Code: 0623

Contact Details: Purchase the Domal Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Domal Pharma S A S report to view the information.
Financial Auditors:
Purchase the Domal Pharma S A S report to view the information.
Incorporation Date:
November 05, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Domal Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-33.34%
Total operating revenue
-33.34%
Operating profit (EBIT)
368.66%
Net Profit (Loss) for the Period
368.66%
Total Assets
51.44%
Total Equity
25.13%
Operating Profit Margin (ROS)
9.56%
Net Profit Margin
6.22%
Return on Equity (ROE)
8.8%
Quick Ratio
-0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?